Industry

Longer-term follow up in the FLAURA2 Phase III trial confirms the favorable benefit-risk profile of this combination Overall survival results reinforce TAGRISSO as the backbone therapy in EGFRm lung cancer across stages WILMINGTON, Del.–(BUSINESS WIRE)–Positive high-level results from the final overall survival (OS) analysis of the FLAURA2 Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) with … [Read more…]

Dr. Alaa Murabit, TIME100 honoree, Gates Foundation Alum, and global security leader, will lead 500 Global’s Sustainable Growth practice in emerging markets, advancing the firm’s commitment to increase blended finance and public-private investment models that unlock innovation and inclusive economic development. SAN FRANCISCO–(BUSINESS WIRE)–500 Global, one of the world’s most active venture capital firms1, today … [Read more…]

Novel preservative-free CBT-004 eye drop formulation demonstrates statistically significant improvements in conjunctival hyperemia and patient-reported symptoms with excellent safety profile IRVINE, Calif.–(BUSINESS WIRE)–#clinicaltrials–Cloudbreak Pharma Inc. a clinical-stage ophthalmology company developing innovative therapies for ocular surface diseases, today announced positive topline results from its Phase 2 clinical trial evaluating CBT-004 ophthalmic solution in patients with vascularized … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: Shortly after 2:30 p.m. ET today, Sarepta received an informal request from the U.S. Food and Drug Administration (FDA) to voluntarily halt shipment of ELEVIDYS (delandistrogene moxeparvovec), our gene therapy for Duchenne muscular dystrophy (Duchenne), … [Read more…]

ONTARIO, Calif.–(BUSINESS WIRE)–Prime Healthcare Services will report earnings the morning of August 12th, 2025, to be followed by a conference call at 2:00 p.m. (ET) to discuss the reported results. Please ensure you pre-register prior to the call by emailing EGarcia27@primehealthcare.com to facilitate attaining your individual pin that will allow direct access to the call. … [Read more…]

Paubox survey reveals rural providers are struggling with every major challenge—from staffing to infrastructure—as cyber threats rise SAN FRANCISCO–(BUSINESS WIRE)–#emailsecurity–As cyber threats grow more frequent and sophisticated, rural hospitals and clinics face challenges on all fronts—tight budgets, limited staff, inadequate training, complex technology, and unsupportive vendors. Many are left trying to manage security tools without … [Read more…]

DEERFIELD, Ill.–(BUSINESS WIRE)–TerSera Therapeutics LLC, a biopharmaceutical company with a focus in oncology, rare disease, and non-opioid pain management, announced today that its collaborative research on intrathecal ziconotide (PRIALT®) prescribing patterns has been accepted for presentation at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN) taking place July 17-20, 2025, … [Read more…]

PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #Anemia—Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 INDEPENDENCE trial evaluating Reblozyl® (luspatercept-aamt) with concomitant janus kinase inhibitor (JAKi) therapy in adult patients with myelofibrosis-associated anemia receiving red blood cell (RBC) transfusions did not meet its primary endpoint of RBC transfusion independence during any consecutive 12-week period, starting within the … [Read more…]

LEHI, Utah–(BUSINESS WIRE)–Weave (NYSE: WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced it will release its financial results for the second quarter 2025 after U.S. markets close on Thursday, July 31, 2025. Company management will host a conference call and webcast at 4:30 p.m. ET … [Read more…]

HOUSTON–(BUSINESS WIRE)–PathoCare Holdings, Inc.—the parent company of medical diagnostics innovator PathoCare, LLC (a leader in the Lab-on-a-Chip non-invasive Point of Care diagnostics)—has developed a set of tests backed by a revolutionary Raman spectroscopy-based testing platform that is underpinned by 17 patents and adaptive AI. Today, the company announced that it has accepted a third-party tender … [Read more…]